Genomic Roadmap for Sarcoma Established

Author: The Cancer Genome Atlas Research Network
Published On: 05/07/18/2018

Soft tissue cancers, including malignant peripheral nerve sheath tumors arising in people with Neurofibromatosis type 1 (NF1), have recently undergone comprehensive genetic and genomic analyses. This landmark study, involving Drs. Brian Van Tine (Medical Oncology) David H. Gutmann (Neurology) and Li Ding (Genetics) from Washington University, characterized over 200 adult sarcomas representing six different types of these cancers.

They demonstrate that different molecular changes characterize each subtype of sarcoma, providing new insights into the biology of these deadly cancers. In addition to examining a small number of malignant peripheral nerve sheath tumors, they also discovered mutations in the NF1 gene in many of these cancers.

Taken together, this important study reveals new potential therapies for these malignant tumors.

For the rest of the story click here.


Want to view archived newsletters? Click Here!

Newsletter

Sign up to receive the latest neurofibromatosis news and information in your inbox!

Subscribe

Categories

Have a story you'd like to share with the NF community? Click Here!